Skip to main content

Table 3 Group means and standard deviations for Joint Moments; Sig†, p < 0.005.

From: The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients

 

PAD pre

PAD post

Control

p-values (effect size)

(%BWxBH)

mean

S.D.

mean

S.D.

mean

S.D.

pre/post

pre/con

post/con

ADMM

-3.41

0.97

-3.05

0.82

-3.74

1.11

0.030 (0.40)

0.241 (0.32)

0.011 (0.72)

APMM

14.84

1.62

15.54

1.69

15.05

1.57

0.036 (0.42)

0.632 (0.13)

0.266 (0.30)

KFMM

2.00

1.64

1.97

2.04

1.73

1.34

0.912 (0.02)

0.494 (0.19)

0.602 (0.14)

KEMM

-6.59

2.50

-6.61

2.30

-8.42

2.48

0.950 (0.01)

0.009 (0.74)

0.007 (0.76)

HFMM

8.67

3.23

8.21

3.10

11.09

2.40

0.371 (0.14)

0.003† (0.86)

< 0.001† (1.04)

HEMM

-8.27

2.31

-8.69

2.45

-10.28

2.70

0.160 (0.17)

0.005 (0.80)

0.027 (0.62)

  1. ADMM - Peak ankle dorsiflexion moment during early stance; APMM - Peak ankle plantarflexion moment during late stance; KFMM - Peak knee flexion moment during stance; KEMM - Peak knee extension moment during stance; HFMM - Peak hip flexion moment during late stance; HEMM - Peak hip extension moment during early stance.